Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
News Release
Mitchell and Genex sign merger agreement that brings together leaders in medical compliance, cost containment and clinical solutions
Genex to become a new division, continuing to deliver industry leading clinical solutions
PDF
Article
Before You Choose a PBM, do the Math
Workers' Comp
Podcast
Five Initial Evaluation Issues That May Delay Return to Work
Workers' Comp
News Release
Business Insurance: Creams cut pain, but price is the rub
Topical creams are becoming part of the mix of pain treatment options as doctors look for alternatives to addictive opioids.
Mitchell
Article
The Impact of Tariffs on the Automotive Claims Industry
There has been a significant amount of press coverage surrounding the potential imposition of a 25 percent tariffs on automobiles and auto parts im
Mitchell
Article
KPI Spotlight: Percentage of Repair for Individual Part Types
In our recent article, “Mitchell Collision Repair